KalVista Pharmaceuticals

KalVista Pharmaceuticals

Oral small-molecule protease inhibitors for rare diseases.

HQ location
Cambridge, United States
Founding location
Southampton, United Kingdom
Launch date
Employees
Market cap
$684m
Enterprise value
$470m
Share price
$13.51 KALV
Company register number
Authorizing premium user...